CUE-101
Cue Biopharma
['head and neck']
this afternoon at #asco22, dr. christine chung shares early results from the cue-101-01 ongoing first-in-human study in hla-a*0201 patients with hpv16+ recurrent/metastatic head and neck squamous cell carcinoma. view abstract: 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.